Archean Chemical Industries files revised SAST disclosure for Chemikas Speciality LLP

What Archean Chemical Industries announced

Archean Chemical Industries Ltd (BSE: 543657) reported that on 13 July 2026 it submitted a revised disclosure to the Bombay Stock Exchange under Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The filing pertains to its shareholding in Chemikas Speciality LLP. The company did not provide any quantitative details such as the number of shares acquired, the purchase price, or the percentage of stake held.

Revised disclosure under SEBI (SAST) Regulations

The revised filing replaces an earlier submission made by Archean Chemical Industries concerning the same transaction. Under SEBI’s SAST framework, any entity acquiring a substantial shareholding (generally 5% or more) in a listed company or a related entity must disclose the acquisition to the stock exchanges within a stipulated time frame. Regulation 31(1) mandates the initial disclosure, while Regulation 31(2) requires a revised statement if there are material changes to the original information, such as a change in the number of shares held or the consideration paid.

"The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 13, 2026 for Chemikas Speciality LLP." – BSE filing

The filing does not elaborate on the nature of the revision—whether it reflects an increase in stake, a change in payment terms, or a correction of earlier data.

Regulatory background

SEBI’s SAST regulations aim to ensure transparency in takeover activities and protect the interests of minority shareholders. The key obligations include:

• Prompt disclosure of any acquisition that crosses the 5% threshold.
• Continuous updating of shareholding details as the transaction evolves.
• Submission of a final statement once the acquisition is complete.

A revised disclosure, as filed by Archean Chemical Industries, signals that the company is complying with the requirement to keep the market informed of any material changes.

Key facts at a glance

Why this matters for investors

The filing confirms that Archean Chemical Industries is actively pursuing or has completed a share purchase in Chemikas Speciality LLP, a move that could affect its strategic positioning in the chemicals sector. While the absence of disclosed financial figures prevents a precise assessment of the transaction’s size, the regulatory filing itself demonstrates compliance with SEBI’s transparency norms. Investors should monitor subsequent disclosures, especially any final statement that may reveal the exact stake and consideration involved.

Conclusion

Archean Chemical Industries Ltd has filed a revised SEBI SAST disclosure on 13 July 2026 concerning its shareholding in Chemikas Speciality LLP. The filing satisfies regulatory requirements but does not disclose the transaction’s monetary value or percentage stake. Further updates are expected if the company files a final statement or provides additional details in future disclosures.